Skip to NavigationSkip to content

News

In the first study, the combo was found to generate an objective response rate of 21.4% in the treatment of unresectable or advanced melanoma which...
AstraZeneca and MSD’s Lynparza (olaparib) has been recommended for marketing authorisation across the European Union for the first-line maintenance...
Acella Pharmaceuticals is recalling two types of its thyroid medication as the drugs may be too weak to properly treat those who take them.
Dr Susanne Schaffert, President of Novartis Oncology said: “These data demonstrating survival benefit give the 40% of HR+/HER2- advanced breast...
The Centers for Disease Control and Prevention has identified nearly 11,000 people who were potentially exposed to coronavirus while flying.
The results mark an improvement in overall response compared to data shared on the drug in this indication back in May, and no new safety signals...
Roche says that its Actermra/Roactemra drugs reduce the likelihood that coronavirus patients with virus-related pneumonia will need to be put on a...
Russian Minister of Health Mikhail Murashko told journalists on 15 September that, so far, more 300 people have been vaccinated with Sputnik V, with...
The lawsuit targets the opioid medication Duragesic, which is a patch that contains fentanyl which the FDA first approved in 1990. It claimed to...
The top ten news stories this week centre around coronavirus vaccines, with Russia signing a deal with an Indian pharma firm to test and deliver 100...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches